Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl E Griswold

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2003
pH sensing agar plate assays for esterolytic enzyme activityKarl E Griswold
Current Opinion in Structural Biology|June 21, 2016
Design and engineering of deimmunized biotherapeuticsKarl E Griswold, Chris Bailey-Kellogg
FEMS Microbiology Letters|February 12, 2015
Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agentDaniel C Osipovitch, Karl E Griswold
Antimicrobial Agents and Chemotherapy|October 17, 2012
Alginate lyase exhibits catalysis-independent biofilm dispersion and antibiotic synergyJohn W Lamppa, Karl E Griswold
RNA (New York, N.Y.)|September 1, 2005
Direct selection of trans-acting ligase ribozymes by in vitro compartmentalizationMatthew Levy, Karl E Griswold, Andrew D Ellington
Journal of Computational Chemistry|January 10, 2013
Structure-based redesign of proteins for minimal T-cell epitope contentYoonjoo Choi, Karl E Griswold, Chris Bailey-Kellogg
Applied Microbiology and Biotechnology|February 19, 2015
Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activityDaniel C Osipovitch, Sophie Therrien, Karl E Griswold
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|April 10, 2010
Protein fragment swapping: a method for asymmetric, selective site-directed recombinationWei Zheng, Karl E Griswold, Chris Bailey-Kellogg
Journal of Bioinformatics and Computational Biology|April 28, 2011
Optimization of therapeutic proteins to delete T-cell epitopes while maintaining beneficial residue interactionsAndrew S Parker, Karl E Griswold, Chris Bailey-Kellogg
Journal of Biotechnology|December 11, 2012
Engineering Escherichia coli for soluble expression and single step purification of active human lysozymeJohn W Lamppa, Sam A Tanyos, Karl E Griswold
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2003
pH sensing agar plate assays for esterolytic enzyme activityKarl E Griswold
Current Opinion in Structural Biology|June 21, 2016
Design and engineering of deimmunized biotherapeuticsKarl E Griswold, Chris Bailey-Kellogg
FEMS Microbiology Letters|February 12, 2015
Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agentDaniel C Osipovitch, Karl E Griswold
Antimicrobial Agents and Chemotherapy|October 17, 2012
Alginate lyase exhibits catalysis-independent biofilm dispersion and antibiotic synergyJohn W Lamppa, Karl E Griswold
RNA (New York, N.Y.)|September 1, 2005
Direct selection of trans-acting ligase ribozymes by in vitro compartmentalizationMatthew Levy, Karl E Griswold, Andrew D Ellington
Journal of Computational Chemistry|January 10, 2013
Structure-based redesign of proteins for minimal T-cell epitope contentYoonjoo Choi, Karl E Griswold, Chris Bailey-Kellogg
Applied Microbiology and Biotechnology|February 19, 2015
Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activityDaniel C Osipovitch, Sophie Therrien, Karl E Griswold
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|April 10, 2010
Protein fragment swapping: a method for asymmetric, selective site-directed recombinationWei Zheng, Karl E Griswold, Chris Bailey-Kellogg
Journal of Bioinformatics and Computational Biology|April 28, 2011
Optimization of therapeutic proteins to delete T-cell epitopes while maintaining beneficial residue interactionsAndrew S Parker, Karl E Griswold, Chris Bailey-Kellogg
Journal of Biotechnology|December 11, 2012
Engineering Escherichia coli for soluble expression and single step purification of active human lysozymeJohn W Lamppa, Sam A Tanyos, Karl E Griswold
Pageof 6